Culture and characterisation of canine mitral valve interstitial and endothelial cells by Liu, M. M. et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Culture and characterisation of canine mitral valve interstitial and
endothelial cells
Citation for published version:
Liu, MM, Flanagan, TC, Lu, CC, French, AT, Argyle, DJ & Corcoran, BM 2015, 'Culture and characterisation
of canine mitral valve interstitial and endothelial cells' Veterinary Journal, vol. 204, no. 1, pp. 32-39. DOI:
10.1016/j.tvjl.2015.01.011
Digital Object Identifier (DOI):
10.1016/j.tvjl.2015.01.011
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Veterinary Journal
Publisher Rights Statement:
This is the author's final peer-reviewed manuscript as accepted for publication.
The final published version is available here:
http://www.sciencedirect.com/science/article/pii/S1090023315000295
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
                             Elsevier Editorial System(tm) for The Veterinary Journal 
                                  Manuscript Draft 
 
 
Manuscript Number: YTVJL-D-14-00751R2 
 
Title: Culture and characterisation of canine mitral valve interstitial and endothelial cells  
 
Article Type: Original Article 
 
Keywords: Valve interstitial cell; Valve endothelial cell; Cell culture; Canine; Myxomatous mitral valve 
disease. 
 
Corresponding Author: Prof. Brendan Corcoran, MVB PhD 
 
Corresponding Author's Institution: University of Edinburgh 
 
First Author: Brendan Corcoran, MVB PhD 
 
Order of Authors: Brendan Corcoran, MVB PhD; Meng Meng Liu; Tom Flangan; Chi-Chien Lu; Anne 
French; David Argyle 
 
Abstract: Valve interstitial cells (VICs) have an important role in the aetiopathogenesis of myxomatous 
mitral valve disease (MMVD) in the dog. Furthermore, there is evidence that valve endothelial cells 
(VECs) also contribute to disease development. In addition to examining native valve tissue to 
understand MMVD, another strategy is to separately examine VIC and VEC biology under in vitro 
culture conditions. The aim of this study was to isolate and characterise canine mitral VICs and VECs 
from normal dog valves using a combination of morphology, immunohistochemistry and reverse 
transcription PCR (RT-PCR).  
 
Canine mitral VECs and VICs were isolated and cultured in vitro. The two cell populations exhibited 
different morphologies and growth patterns. VECs, but not VICs, expressed the endothelial markers, 
platelet endothelial cell adhesion molecule (PECAM-1 or CD31) and acetylated low density lipoprotein 
(Dil-Ac-LDL). Both VECs and VICs expressed vimentin and embryonic non-smooth muscle myosin 
heavy chain (SMemb), an activated mesenchymal cell marker. The myofibroblast marker, alpha smooth 
muscle actin (α-SMA), was detected at the mRNA level in both VEC and VIC cultures, but only at the 
protein level in VIC cultures. The morphological heterogeneity and expression of non-endothelial 
phenotypic markers in VEC cultures suggested that a mixture of cell types was present, which might be 
due to cell contamination and/or endothelial mesenchymal transition (EndoMT). The use of a specific 
endothelial culture medium for primary VEC cultures enhanced the endothelial properties of the cells 
and reduced α-SMA and SMemb expression.  
 
 
 
 
 
Culture and characterisation of canine mitral valve interstitial and endothelial cells  1 
 2 
M-M. Liu a, T.C. Flanagan b, C-C. Lu a, A. T. French c, D.J. Argyle a, B.M. Corcoran a,* 3 
 4 
aRoyal (Dick) School of Veterinary Studies and The Roslin Institute, the University of 5 
Edinburgh, Easterbush, Roslin, Mid-Lothian, Scotland, UK EH25 9RG. 6 
bSchool of Medicine & Medical Science, Health Sciences Centre, University College Dublin, 7 
Belfield, Dublin 4, Ireland. 8 
cUniversity of Glasgow School of Veterinary Medicine, Bearsden Road, Glasgow, G61 1QH, 9 
Scotland, UK 10 
 11 
*Corresponding Author: Tel: +44 (0)131 651 9100 12 
E-mail address: Brendan.Corcoran@ed.ac.uk (Brendan Corcoran) 13 
 14 
 15 
16 
Manuscript
Click here to view linked References
Abstract 17 
Valve interstitial cells (VICs) have an important role in the aetiopathogenesis of 18 
myxomatous mitral valve disease (MMVD) in the dog. Furthermore, there is evidence that 19 
valve endothelial cells (VECs) also contribute to disease development. In addition to 20 
examining native valve tissue to understand MMVD, another strategy is to separately 21 
examine VIC and VEC biology under in vitro culture conditions. The aim of this study was to 22 
isolate and characterise canine mitral VICs and VECs from normal dog valves using a 23 
combination of morphology, immunohistochemistry and reverse transcription PCR (RT-24 
PCR).  25 
 26 
Canine mitral VECs and VICs were isolated and cultured in vitro. The two cell 27 
populations exhibited different morphologies and growth patterns. VECs, but not VICs, 28 
expressed the endothelial markers, platelet endothelial cell adhesion molecule (PECAM-1 or 29 
CD31) and acetylated low density lipoprotein (Dil-Ac-LDL). Both VECs and VICs expressed 30 
vimentin and embryonic non-smooth muscle myosin heavy chain (SMemb), an activated 31 
mesenchymal cell marker. The myofibroblast marker, alpha smooth muscle actin (α-SMA), 32 
was detected at the mRNA level in both VEC and VIC cultures, but only at the protein level 33 
in VIC cultures. The morphological heterogeneity and expression of non-endothelial 34 
phenotypic markers in VEC cultures suggested that a mixture of cell types was present, 35 
which might be due to cell contamination and/or endothelial mesenchymal transition 36 
(EndoMT). The use of a specific endothelial culture medium for primary VEC cultures 37 
enhanced the endothelial properties of the cells and reduced α-SMA and SMemb expression.  38 
 39 
Keywords: Valve interstitial cell; Valve endothelial cell; Cell culture; Canine; Myxomatous 40 
mitral valve disease. 41 
42 
Introduction 43 
Myxomatous mitral valve disease (MMVD) is characterised by extensive changes to 44 
the valve extra cellular matrix (ECM), resulting in valve distortion and mechanical instability, 45 
and leading to valve insufficiency and mitral regurgitation (Black et al., 2005; Hadian et al., 46 
2007; Aupperle et al., 2009, 2010; Han et al., 2010, 2013b). The mechanisms that lead to 47 
valve degeneration are not fully understood, but are presumed to involve changes in valve 48 
interstitial cell (VIC) and endothelial cell (VEC) phenotype and function (Corcoran et al., 49 
2004; Disatian et al., 2008; Han et al., 2008, 2013a). Endothelial changes are characterised by 50 
detachment, denuding and apoptosis with splitting of the basement membrane and increased 51 
expression of basement membrane proteins, including laminin (Aupperle et al., 2009; Han et 52 
al., 2013a). VICs show an activated myofibroblast phenotype and their numbers decline in 53 
the overly myxomatous areas and proliferate close to the valve surface, most noticeably 54 
where there has been endothelial damage (Disatian et al., 2008; Han et al., 2008, 2013a).  55 
 56 
VICs are the cells contributing to ECM production and remodelling. Their synthetic 57 
activity is driven mainly by the transforming growth factor beta (TGF-β) cytokine 58 
superfamily, but is also thought to be modified by signals from the endothelial cells (Olsen et 59 
al., 2003; Disatian et al., 2010; Aupperle and Disatian, 2012; Orton et al., 2012; Han et al., 60 
2013a). This VEC-VIC interaction has led to the hypothesis that VEC activation is 61 
fundamental to valve matrix homeostasis and that MMVD may be driven by mechanisms 62 
involving VEC damage and leading to aberrant matrix remodelling.  63 
 64 
Future examination of MMVD will require a greater understanding of VEC-VIC 65 
interactions and one approach is to do so using in vitro models. Canine mitral VICs have 66 
been previously isolated and cultured using a primary explant technique which favours 67 
culturing migratory cells only, but there was limited phenotypic characterisation, and there 68 
are no reports of successful cultures of canine VECs (Heaney et al., 2009). The aims of this 69 
study, therefore, were (1) to develop robust methods for the culture and phenotypic 70 
characterisation of canine mitral VICs and VECs based on a reported protocol for porcine 71 
aortic valve cell isolation (Gould and Butcher, 2010), and (2) to examine canine mitral valve 72 
cell biology under the culture conditions. Furthermore, as it is recognised to be difficult to 73 
maintain endothelial cell phenotype in VEC culture, different culture protocols were 74 
evaluated. 75 
 76 
Materials and methods 77 
Cell isolation and culture 78 
Cells were isolated from 12 healthy canine mitral valves showing no MMVD 79 
evidence on gross morphological inspection. The dogs were of different breeds, aged 2-5 80 
years and with equal sex distribution. All dogs were euthanased for reasons other than cardiac 81 
disease. Samples were collected with full owner consent and sampling conformed to 82 
institutional and national ethical guidelines. 83 
 84 
Mitral valves were removed within minutes of euthanasia under sterile conditions, 85 
rinsed in cold sterile phosphate buffered saline (PBS) and placed on ice until transferred to a 86 
tissue culture laminar hood. Excess annular tissue and chordae tendineae were removed, and 87 
samples were placed in 35 mm petri dishes and incubated with 5 mL pre-warmed collagenase 88 
solution (600 Units/ml) in 5% CO2 for 10 min at 37 ºC. VECs were removed by gently 89 
rotating a dry sterile swab over the surface of the leaflet and occasionally dabbing the swab 90 
into the collagenase solution. The collagenase solution was aspirated and the suspended cells 91 
pelleted by centrifuging at 1000g for 5 min at room temperature. The supernatant was 92 
aspirated and the cells were re-suspended in advanced DMEM/F-12 medium (Life 93 
Technologies) with 10% foetal bovine serum (FBS), 1% penicillin/streptomycin and 1% L-94 
glutamine (AF-12). Cells were centrifuged, re-suspended again and seeded on culture flasks 95 
or plates pre-coated with 2% gelatin and incubated at 37 °C in 5% CO2. After VEC 96 
collection, tissue was placed in a 15 mL conical tube with 10 mL collagenase solution (600 97 
U/mL) and incubated for 18 h at 37 °C in 5% CO2. After digestion, the tissue was 98 
homogenized in the collagenase solution. The released cells were then seeded onto flasks and 99 
cultured as described for VECs in AF-12 medium.  100 
 101 
Media changes occurred at 2 day intervals for both populations. At confluence, cells 102 
were passaged by either trypsinization (0.05% - 1% Trypsin /EDTA) or by using 1 x TrypLE 103 
Express (Life Technologies). In general, VECs were expanded up to passage three and VICs 104 
were cultured up to passage 8. 105 
 106 
Comparison of two culture media for canine mitral VECs  107 
To evaluate the effect of specific endothelial culture medium on primary VEC 108 
properties, a canine endothelial basal medium kit (Cn 211k-500, Cell Application; EBM) was 109 
compared with the AF-12 medium for VECs.  VEC preparations (at passages 1-2) from 110 
different dogs (n = 3) were used for the medium comparison experiment. Prior to the medium 111 
switch, cells were stored in freezing medium (70% AF-12 medium/20% FBS/10% 112 
dimethylsulphoxide (DMSO; Invitrogen)) and cryopreserved in -150 °C freezer or in liquid 113 
nitrogen freezer. Cells were revived in a 37 °C water bath, and were washed with pre-warmed 114 
AF-12 medium by centrifuging. After removal of the supernatant, the cells were re-suspended 115 
in canine EBM and seeded onto culture plates pre-coated with 2% gelatin and incubated at  116 
37 °C in 5% CO2. Control cultures were maintained in AF-12 for the same VEC preparation. 117 
VEC cultures in EBM and AF-12 were harvested at confluence and evaluated for endothelial 118 
and mesenchymal marker expression.  119 
 120 
Reverse transcription-polymerase chain reaction (RT-PCR) 121 
Total RNA was isolated from both cell types using the RNeasy Mini Kit (Qiagen), 122 
according to the manufacturer’s protocol. Extracted RNA was treated with RNase-free DNase 123 
I and concentration of RNA was measured using NanoDrop (Thermal Scientific). RNA was 124 
diluted using nuclease-free water (Qiagen) and was denatured at 65 °C for 5 min, then placed 125 
immediately on ice. Complementary DNA was synthesized using an Omniscript Reverse 126 
Transcription Kit (Qiagen) at 40 °C for 1 h.  127 
 128 
The following genes (Table 1) were selected to characterise the VECs and VICs: 129 
CD31 and von Willebrand Factor (vWF) (endothelial markers); alpha-smooth muscle actin 130 
(α-SMA), embryonic form of non-smooth muscle myosin (SMemb) and transgelin (SM22) 131 
(activated VIC (aVIC) markers); vimentin (mesenchymal origin cells). GAPDH was used as a 132 
housekeeping gene. The primers of vWF-1, α-SMA and GAPDH were kind gifts (Hannah 133 
Hodgkiss-Geere, the University of Edinburgh), and vWF3 primer sequence was derived from 134 
Fulton et al. (2000). All other primers were originally designed using Primer 3 Input v.4.0 135 
and nucleotide sequences of the above markers were obtained from the NCBI Gene Bank or 136 
Ensembl databases. 137 
 138 
PCR amplification used the Gotaq PCR Core System (Promega). Initial denaturation 139 
at 95 °C for 5 min was followed by 30 cycles of 95 °C for 1 min, 58-61 °C for 1 min, 72 °C 140 
for 1 min and a final extension at 72 °C for 10 min. PCR products were analysed using a 141 
standard 2% agarose gel electrophoresis. Molecular Imager Gel Doc system (Bio-Rad) was 142 
used to visualize the results after electrophoresis. 143 
 144 
Immunocytochemistry 145 
The cell suspension (200 µL) was added to duplicate BD Falcon Culture slides, pre-146 
coated with 2% gelatin for VECs, at a density of 1 x 104 cell/well and incubated in 5% CO2 at 147 
37 °C for 24-48 h. Slides were directly fixed with acetone for 10 min at -20 oC, washed twice 148 
in PBS, incubated for 1 h in blocking buffer (10% goat serum/0.1% Tween 20/PBS) and then 149 
overnight in a humidity chamber at 4 °C with primary antibodies against CD31, vimentin, 150 
SMemb and α-SMA (Table 2). Slides were washed twice with PBS and incubated with 100 151 
µL goat anti-rabbit IgG or goat anti-mouse IgG secondary antibody for 1 h at room 152 
temperature in a dark humid chamber. The slides were then washed three times in PBS, 4',6-153 
diamidino-2-phenylindole (DAPI) mounted (Vectashield Mounting Medium,Vector Inc), and 154 
examined using a Leitz fluorescence microscope (Leica). 155 
 156 
DiI- acetylated-low density lipoprotein (DiI-Ac-LDL) labelling 157 
Acetylated low density lipoprotein conjugated with fluorescence dye 1, 1’-158 
dioctadecyl-3, 3, 3’, 3’-tetramethyl-indocarbocyanine perchlorate (DiI-Ac-LDL) was used to 159 
detect endothelial cells. The cell culture protocol prior to labelling was the same as that 160 
described for immunocytochemistry. DiI-Ac-LDL (200 µL; 5 µg/mL; BT902, Biomedical 161 
Technologies) reagent was added to one cell chamber and incubated for 4 h in 5% CO2 at 37 162 
°C. Slides were washed three times with PBS and were examined by fluorescence and bright 163 
field microscopy.  164 
 165 
Image capture and processing 166 
            Cell morphology was observed by light microscopy during the culture period and 167 
assessed for cell morphology and confluence. Representative images were captured using a 168 
camera connected Zeiss Axiover 40 microscope. Immunofluorescence and DiI-Ac-LDL 169 
fluorescent channel images were captured using a Leica Firecam (Leica). For optimal 170 
visualization of the fluorescence signals, the antibody and DAPI staining images were 171 
converted into grayscale with Image J software. Original antibody and DAPI channel colour 172 
images were merged using Adobe Photoshop CS6 software (Adobe System). For DiI-Ac-173 
LDL labelling, bright field images were taken from the same sampled area demonstrating cell 174 
distribution and were converted into grayscale images with ImageJ software. 175 
 176 
Results 177 
Cell culture morphology and growth 178 
            By using current collagenase digestion techniques, VEC and VIC were successfully 179 
isolated from the same mitral valve (n = 12) and grew well in all sub-cultures. The two 180 
culture types showed differences in cell morphology and growth pattern. 181 
 182 
Endothelial colony-forming cell clusters were randomly distributed in VEC culture 183 
flasks 1-2 days post primary isolation, and clustering promoted outgrowth. Cells had 184 
cobblestone morphology typical of endothelial cells in culture, and most noticeably at 185 
confluence (Fig.1). Confluence of passage 0 VECs was usually reached within 6-8 days in 186 
one T80 flask when most cells exhibited growth contact inhibition and formed a monolayer. 187 
Some cell polymorphism was also noted with spindle shapes and multiple cytoplasmic 188 
extensions, which increased in numbers with increasing passages.  189 
 190 
Cultured VICs typically had a spindle shape reminiscent of a fibroblast-like 191 
morphology, although heterogeneous morphologies were also observed, and the cells 192 
proliferated readily in culture (Fig.1). At confluence, the cells tended to form a whorl-like 193 
pattern with multiple layers and did not exhibit growth contact inhibition (Fig. 1). Primary 194 
passage 0 VICs usually reached at confluence in a T80 flask within 3 days. 195 
 196 
VEC phenotypic characterization 197 
Phenotypic characterization was performed on 3-4 VEC cell lines (at passages 2-3) 198 
derived from different dogs. By RT-PCR, VECs expressed CD31, vimentin, as well as α-199 
SMA, SMemb and SM22 (Fig. 2). Expression of vWF was not apparent in canine mitral 200 
VECs, and this finding was consistently observed with three different vWF primer pairs. All 201 
vWF primer pairs were validated by probing cDNA of two endothelial nature cell lines (one 202 
human umbilical vascular endothelial cell line and one canine haemangiosarcoma cell line), 203 
in which the expression was clearly identified (data not show).  204 
 205 
By immunofluorescence, CD31 was identified in VECs, particularly at cell-cell 206 
junctions (Fig. 3). VECs also extensively expressed vimentin and SMemb in the cytoplasm 207 
(Fig. 3), while α-SMA expression was limited and only detected in a few cells from one 208 
culture. The endothelial identity of the VEC culture was also confirmed by DiI-Ac-LDL 209 
uptake (Fig. 3). 210 
 211 
Effects of culture media on VEC culture characteristics 212 
Replacing standard culture medium (AF-12) with EBM helped to maintain a more 213 
endothelial phenotype as determined by morphological assessment. Cells in both media 214 
showed Dil-Ac-LDL up-take and CD31 expression, but staining was more intense in cells 215 
cultured with EBM (Fig. 4). At the transcriptional level, higher CD31 expression was 216 
observed in EBM cultures compared with AF-12 cultures, while α-SMA and SMemb 217 
expression was reduced in the EBM cultures compared to AF-12 cultures (Fig. 5). 218 
VIC phenotypic characterization  219 
Phenotypic characterization was performed on 3-5 VIC cell lines (at passages 4-7) 220 
derived from different dogs. By RT-PCR, α-SMA, vimentin, SM22 and SMemb were 221 
expressed in VIC cultures in contrast to CD31 (Fig. 2). By immunofluorescence, VIC 222 
cultures were also consistently negative for CD31 expression (Fig. 6). Similar to VECs, VICs 223 
showed extensive cytoplasmic expression of vimentin and SMemb. α-SMA expression was 224 
observed in the cytoplasm, although the expression level varied between different cultures, 225 
with an estimated average of 10% cell expression. No VIC cultures showed DiI-Ac-LDL 226 
uptake (Fig. 6). 227 
 228 
Discussion 229 
VICs have been previously cultured from dog mitral valves from normal dogs and in 230 
one study from dogs with mild MMVD (Heaney et al., 2009; Waxman et al., 2012). In the 231 
study by Heaney et al. (2009), cultures were initiated up to 36 h after death (Heaney et al., 232 
2009). Furthermore, their protocol favoured migratory cells, resulting in suboptimal VIC 233 
isolation and culture (Taylor et al., 2000). Waxman et al. (2012) isolated mitral VICs using 234 
the same collagenase digestion technique as in our study, but from a limited number of 235 
laboratory Beagles that were healthy or with mild MMVD. VIC characteristics in a standard 236 
tissue culture system, however, were not evaluated. To date there are no reports of culture 237 
and characterisation of VECs collected from canine valves immediately after death.  238 
 239 
In the current study, canine mitral VECs and VICs were successfully isolated from the 240 
same subjects, cultured and characterized. Relatively pure cell populations were obtained and 241 
there was differential expression of a range of known mitral valve cell phenotypic markers. 242 
This provides fundamental information on canine mitral valve cell biology, which will 243 
benefit mitral valve disease research. 244 
 245 
VECs are known to express CD31 and to show selective uptake of DiI-Ac-LDL 246 
through endocytosis. These properties allow confirmation of an endothelial origin (Cuy et al., 247 
2003; Gould and Butcher, 2010). The lack of expression of vWF was unexpected, but could 248 
be due to a tissue-specific heterogeneous expression of vWF, as has been previously observed 249 
in endothelium from different anatomic sites (Pusztaszeri et al., 2006). A previous report on 250 
porcine mitral VECs also found vWF expression to be weak at the transcriptional level 251 
(Flanagan et al., 2006). The majority of VECs exhibited typical cobblestone morphology, but 252 
cellular pleomorphism was also present with spindle-shaped cells reminiscent of interstitial 253 
cells and fibroblasts. This may be explained by valve-side heterogeneity (as found in aortic 254 
valve VECs), VIC contamination or endothelial mesenchymal transition (EndoMT) to a VIC 255 
phenotype (Simmons et al., 2005; Bischoff and Aikawa, 2011). In the current study, the 256 
mRNA expression of aVIC markers (i.e. SMemb, SM22 and α-SMA) in VEC cultures 257 
suggests the presence of VIC contamination and/or EndoMT in the culture system. VIC 258 
contamination is a common issue in primary VEC cultures when using enzymatic digestion 259 
(Butcher and Nerem, 2007; Cheung et al., 2008). However, cell contamination cannot fully 260 
explain the aVIC characteristics in the VEC cultures, particularly the extensive protein 261 
expression of the activated mesenchymal marker SMemb in VEC. To our knowledge, this is 262 
the first study showing SMemb expression in adult VECs, which suggests that VECs in the 263 
current culture system are in an activated state and have embryonic cell potential reminiscent 264 
of EndoMT.  265 
 266 
EndoMT does involve increased mesenchymal and decreased endothelial marker 267 
expression (Hoerstrup et al., 1998; Cheung et al., 2008; Bischoff and Aikawa, 2011). Such 268 
phenotypic transformation of VECs has been suggested to be similar to what occurs during 269 
valvular development (Person et al., 2005; Butcher and Markwald, 2007; Butcher and Nerem, 270 
2007; Bischoff and Aikawa, 2011). The complexity of the transition from cardiac 271 
endothelium to interstitial cells involves multiple signalling pathways, but particularly 272 
endothelial growth factors and member of the TGF-β superfamily (Armstrong and Bischoff, 273 
2004). The possible EndoMT potential in adult valve cells has been examined previously 274 
(Paruchuri et al., 2006; Paranya et al., 2001; Mahler et al., 2013). It has been hypothesized to 275 
be one of the key remodelling mechanisms in heart valve diseases, where a subset of adult 276 
VECs possess foetal cell characteristics similar to progenitor cells, and can replenish the VIC 277 
population when needed, for example during disease or remodelling process (Paruchuri et al., 278 
2006; Liu et al., 2007; Bischoff and Aikawa, 2011). 279 
 280 
Due to cell contamination and/or in vitro differentiation, the primary VECs were less 281 
stable particularly in long term cultures. Cell purification techniques and special culture 282 
medium favouring endothelial growth are potential solutions to increase VEC purity 283 
(Hoerstrup et al., 1998; Cheung et al., 2008; Gould and Butcher, 2010). In the current study, 284 
these two methods were evaluated separately. Trial cell sorting experiments were performed 285 
on the VECs from one canine mitral valve (data not shown). By using CD146 and flow 286 
cytometry (Wills et al., 2009), over 75% of positive cells were detected in the passage 1 VEC 287 
culture. The separated CD146-positive cells showed stronger endothelial and decreased 288 
mesenchymal properties compared to the unsorted cells in short term cultures. However, 289 
myofibroblast-like morphology re-appeared later when cells reached confluence. This 290 
suggests that even though cell sorting can efficiently separate VECs from a mixed population 291 
culture, a standard cell culture medium (i.e. AF-12) cannot maintain the endothelial 292 
properties in long term cultures. To preserve endothelial features and prevent mesenchymal 293 
differentiation, VECs typically require a specific culture medium containing growth factors 294 
favouring endothelial growth ( Paranya et al., 2001; Wylie-Sears et al., 2011; Ci et al., 2013). 295 
The use of EBM instead of AF-12 resulted in a more consistent VEC phenotype, as 296 
evidenced by enhanced endothelial marker expression and decreased α-SMA and SMemb 297 
expression. However, EBM did not inhibit the proliferation of contaminating cell types. A 298 
combination of cell sorting and of a specific endothelial medium culture could improve the 299 
purity of VECs as well as maintain them for longer culture, however, further investigations 300 
are required to demonstrate it.  For unsorted VECs, early passage (less than passage 3) and 301 
less confluent cells should be used for studies of VECs to guarantee a reasonable culture 302 
purity (Gould and Butcher, 2010). 303 
 304 
Primary VIC cultures exhibited a fibroblast-like morphology, which is consistent with 305 
previous reports (Heaney et al., 2009; Waxman et al., 2012). However, some morphological 306 
variation was observed and a different response to enzymatic dissociation was observed with 307 
some cells showing stronger adhesion than others. This adherence difference has been 308 
associated with differential expression of α-SMA, with near 100% expression in more 309 
adhesive cells (Blevins et al., 2006). The heterogeneity in native VICs has been reviewed by 310 
Liu et al. (2007), who suggested that there are at least five sub-phenotypes. These sub-311 
populations respond to stimulation and environmental changes differently and have different 312 
functions, but currently there is no definitive marker panel to identify each VIC sub-313 
phenotype. In general, VICs do not express VEC markers and are vimentin positive (Liu et 314 
al., 2007; Heaney et al., 2009). VICs are further confirmed by the expression of SMemb, 315 
SM22 and α-SMA, which are thought to indicate VIC activation (aVICs) (Della Rocca et al., 316 
2000; Rabkin et al., 2001; Wiester and Giachelli, 2003; Disatian et al., 2008; Han et al., 2008; 317 
Stephens et al., 2011).  318 
 319 
Recently aVICs have attracted some attention in the valvular research field, as they 320 
were found to play a key role in valve remodelling or stromal degeneration (Rabkin et al., 321 
2001; Disatian et al., 2008; Gupta et al., 2009; Han et al., 2008). In diseased valves, there is 322 
an increase of α-SMA positive cells close to the endothelium, and these aVICs are presumed 323 
to contribute to valve damage and attempts at repair (Disatian et al., 2008; Han et al., 2008). 324 
Moreover, in vitro studies suggest that the aVIC population is dynamic, mechanosensitive 325 
and responsive to external stimulation. For example, culture conditions, such as cell density, 326 
substrate types and movement, can affect the level of α-SMA expression (Engler et al., 2006; 327 
Stephens et al., 2011; Xu et al., 2012). These findings may explain the discrepancy of α-SMA 328 
expression observed between the current study and a previous report (Taylor et al., 2000). 329 
Under culture conditions using three dimensional collagen substrates, the appearance of α-330 
SMA positive cells suggests that a cell population analogous to the disease phenotype is 331 
present, but this can be reversed by mechanical treatment of the cells, reverting them to a 332 
more normal fibroblast phenotype (Waxman et al., 2012). Functional studies of mitral VICs 333 
are required. Cultured mitral VICs are capable of ECM synthesis and are involved in wound 334 
repair (Lester et al., 1993; Durbin et al., 2005; Flanagan et al., 2006; Fayet et al., 2007; Gupta 335 
et al., 2008). The effects of various conditions on canine valve cell phenotype and function 336 
requires further investigation if cultured VECs and VICs are to be used for modelling mitral 337 
valve disease.  338 
Conclusion 339 
The characterisation of canine mitral VECs and VICs demonstrated phenotypic 340 
heterogeneity under the static culture conditions used in the current study. These findings 341 
should contribute to improving the understanding of canine mitral valve cellular biology, and 342 
should benefit mitral valve disease research and tissue engineering studies.      343 
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Table 1. PCR sequences for PCR characterization of valve endothelial cells (VECs) and valve 551 
interstitial cells (VICs). 552 
 553 
554 
Gene Primer Sequence (5’-3’) Product size 
CD31 
AATCCCAAATTCCACGTCAG 
GAATGGAGCACCACAGGTTT 346 bp 
 
vWF1 
CTGGGAGAAGAGAGTCACGG 
GTGGATGGAGTACACGGCTT 
 
235 bp 
vWF2 
GGCTGTACCTGGATGAGAGG 
GACAGGACAGGCTCCTTTTG 228 bp 
vWF3 (Fulton et al., 2000) 
AATATAGGGCCCCGGCTCACTCAA 
ACATCCCCGGGCCTCTTCTCATTC 512 bp 
SM22 
AAGAACGGCGTGATTCTGAG 
CGGTAGTGCCCATCATTCTT 269 bp 
α-SMA 
GGGGATGGGACAAAAGGACA 
GCCACGTAGCAGAGCTTCTCCTTGA 525 bp 
SMemb 
AGAAGCGAGCTGGAAAACTG 
TCTTGCTCTGTCCGATTCTG 252 bp 
Vimentin 
GGAGCAGCAGAACAAGATCC 
AGACGTGCCAAAGAAGCATT 282 bp 
GAPDH 
CATCAACGGGAAGTCCATCT 
GTGGAAGCAGGGATGATGTT 428 bp 
 555 
Table 2. Details of the antibodies used for canine mitral valve endothelial (VEC) and valve 556 
interstitial cell (VIC) immunocytochemistry characterisation. 557 
 558 
Primary antibody Species raised Cat Number & Supplier Dilution 
Anti-CD31 Rabbit polyclonal Ab28364, Abcam, UK 1:200 
Anti-SMemb Rabbit polyclonal  Ab24761, Abcam, UK 1:400 
Anti-vimentin Mouse monoclonal V6389, Sigma, USA 1:1600 
Anti-α-SMA Mouse monoclonal A2547, Sigma, USA 1:400 
Secondary antibody    
Anti-rabbit IgG (H+L) 
Alexa Fluor568 
Goat A11011, Invitrogen, UK 1:500 
Anti-mouse IgG (H+L) 
Alexa Fluor488 
Goat A10667, Invitrogen, UK 1:500 
 559 
560 
Figures Legends 561 
 562 
Figure 1. Canine mitral valve cell morphologies. 563 
Upper Panel; primary isolated canine mitral valve endothelial cell (VEC) morphology. A. At 564 
the early stage, single colony clusters randomly appeared in the cultures. B. Once the cells 565 
reached confluence, the majority exhibited a cobblestone morphology and were growth-566 
contact inhibited. Scale bar = 100 µm.  567 
Lower Panel; primary cultured valve interstitial cell (VIC) morphology before confluence (C) 568 
and at confluence (D). Cells in VIC cultures exhibited fibroblast-like morphology, and tended 569 
to arrange in a ‘hill and valley’ pattern in confluent cultures.  Scale bar = 200 µm. 570 
Figure 2. Canine mitral valve endothelial cells (VECs) and valve interstitial cells (VICs) 571 
characterised by RT-PCR. Upper panel: VECs; the endothelial cell marker (CD31) and the 572 
activated VIC markers (α-SMA, SMemb and SM22) were detected in VECs. Vimentin and 573 
GAPDH were used as internal controls. Lower panel: VICs; cells were negative for the VEC 574 
marker CD31, but positive for α-SMA, SMemb, SM22 and vimentin. cDNA template derived 575 
from a VEC culture was used to amplify CD31 transcripts in the same experiment as a 576 
positive control (data not shown). Vimentin and GAPDH were used as internal controls. 577 
Figure 3. Canine mitral valve endothelial cells (VECs) characterised by 578 
immunohistochemistry and DiI-Ac-LDL. Upper panel; DiI-Ac-LDL uptake by VECs in 579 
culture (A) and cell distribution illustrated by bright field microscopy (B). Scale bar = 100 580 
µm. Lower panel; characterization of canine mitral VEC culture by immunofluorescence. 581 
Cell expressed CD31 (red in C), vimentin (green in G) and SMemb (red in K), but were 582 
negative for α-SMA (O). DAPI (blue) stained cell nuclei. DAPI channel (A, E, I and M), 583 
target protein channel (B, F, J and N) and merged images (C, G, K and O) are shown 584 
respectively for each marker. The same primary cultures cell lines served as negative controls 585 
(primary antibodies were omitted; D, H and L). Cells from a VIC culture showing expression 586 
of α-SMA served as a positive control (P). Scale bar = 50 µm. 587 
Figure 4. Endothelial properties of canine mitral valve endothelial cells (VECs) under 588 
different culture conditions. EBM cultures (left panel) and AF-12 cultures of VECs (right 589 
panel) showing uptake of DiI-Ac-LDL (upper panel) and expression of CD31 (lower panel). 590 
There is a greater intensity of staining for EBM cultures. DAPI (blue) stained cell nuclei. 591 
Scale bar = 100 µm 592 
 593 
Figure 5. Canine mitral canine mitral valve endothelial cells (VECs) under different culture 594 
conditions, characterised by semi-quantitative RT-PCR (arbitrary units compared to the 595 
reference gene GAPDH). Cells in EBM demonstrated higher expression of CD31 and 596 
decreased expression of α-SMA and SMemb compared to VECs and VICs cultured in AF-12. 597 
 598 
Figure 6. Canine mitral valve interstitial cells (VICs) characterised by 599 
immunohistochemistry and DiI-Ac-LDL. Upper panel; lack of DiI-Ac-LDL uptake by VICs 600 
(A) and cell distribution illustrated by bright field microscopy (B). Scale bar = 200 µm. 601 
Lower panel;  characterization of canine mitral VIC culture by immunofluorescence. Cells 602 
expressed vimentin (green in G), SMemb (red in K) and α-SMA (green in O), but were 603 
negative for CD31 (C). DAPI (blue) stained cell nuclei. DAPI channel (A, E, I and M), target 604 
protein channel (B, F, J and N) and merged images (C, G, K and O) are shown respectively 605 
for each marker. The same cell lines served as negative controls (primary antibodies were 606 
omitted; H, L and P). Cells from a VEC culture showing expression of α-SMA served as a 607 
positive control (D). Scale bar = 50 µm. 608 
 609 
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Highlights: 
 
 Successful culturing and characterising of valve interstitial and endothelial cells 
from the same subject. 
 First reported culturing of valve interstitial cells (VICs) that did not favour a 
migratory phenotype. 
 First reported culturing of canine valve endothelial cells (VECs). 
 Assessment of the value of multiple cell markers in cell phenotyping. 
 Identification of CD31 expression and acetylated low density lipoprotein (Dil-Ac-
LDL) uptake as the prime markers for differentiating VECs from VICs. 
 Identification of phenotypic plasticity under culture conditions and optimal 
passage for attaining the purest VEC population. 
*Highlights (for review)
Highlights: 
 
1. Successful culture and characterisation of valve interstitial and endothelial cells 
2. Identification of CD31 expression and Dil-Ac-LDL uptake as the prime markers for 
differentiating VECs from VICs. 
3. A specific endothelial culture medium for primary VEC cultures enhanced the 
endothelial properties of the cells 
*Highlights (for review)
We would like to thank the reviewers for their comments. There were instances where the line 
numbers quoted did not match those of the current version of the manuscript, but we think we have 
managed to respond to each comment in turn.  
Reviewer 1  
Point 1: “The authors are not clear on whether they were able to culture a pure VEC population that 
then subsequently differentiated (e.g. via EndMT) or whether the population was heterogeneous 
(VEC+VIC) to start with. Their aSMA data suggests the latter, but if they combined with IHC of 
normal canine MV, it might support that canine VEC possess aSMA expression in vivo.” 
Response: Indeed, sub-endothelial VIC contamination in primary VECs isolated by enzymatic 
digestion has been recognised as a common technical issue (Cheung et al., 2008; Hoerstrup et al., 
1998). However, we cannot completely rule out the possibility of cell differentiation in culture. 
Firstly, the α-SMA expression in VECs was mainly identified at gene level and it was almost absent at 
protein level. It is difficult to tell whether the α-SMA gene expression was from differentiating VECs 
or contaminating cells or from both. Secondly, which is probably more robust evidence, is the 
extensive expression of activated mesenchymal marker SMemb expression in the VEC cultures. This 
marker has been found highly expressed in embryonic VECs during development or in activated VICs 
during valve disease processes, while in healthy adult heart valves, the expression has been described 
as absent/minimally expressed (Aikawa et al., 2006). Therefore, we propose that the canine mitral 
VECs we cultured in vitro may possess some embryonic differentiation potentials and we have 
addressed the above points in the discussion of the revised manuscript.  
With regards to native valve α-SMA expression, we did look at it in normal canine MV by 
immunofluorescence (data not shown); the expression was very limited and mainly restricted to 
atrialis, and this finding is consistent with our own and others previous reports (Han et al., 2008; 
Disatian et al., 2008). 
Point 2: “Their method is largely similar to that of Gould et al (JoVE 2012), which raises the question 
of whether ECM coating is essential for VEC adhesion. It would be good to know, as that can be a 
real problem out of the gate for others.” 
Response: From our experience, the answer is no. We once accidentally cultured our VECs on 
polypropylene flasks without gelatin coating; the cells still adhered and proliferated, however, with a 
different morphology and the efficiency of adherence was not investigated (data not shown). Indeed, 
it has been reported that additional ECM coating to plastic culture flasks can enhance endothelial cell 
adherence, proliferation and affect endothelial cell morphologies (Relou et al., 1998; Schelling et al., 
1988; Xia et al., 2011). Both gelatin and collagen are commonly used for valve endothelial culture in 
previous reports (Wylie-Sears et al., 2011; Gould and Butcher, 2010). For these reasons, we would 
recommend matrix coating for endothelial culture.  
Point 3: “Also, it isn't clear from my reading of the manuscript whether the VEC cultured in this 
study ended up being suitable for follow-on experiments on VEC behavior. Are enough cells available 
at passage 3 without compromising homogeneity?  
Response: The answer is yes. Primary VECs P0 yields to 0.66 x 106 – 3.5 x 106 depending on dog size 
and valve leaflet collected(anterior/posterior or both), and on average 1.5 x 10
6 
approximately. This 
can further yield to approximate 1.0 x 10
7 
at P1, and around 1 x 10
8 
at P2. This number should be 
sufficient to do routine experiments such as immunocytochemistry (usually 1 x 10
4
 cells per sample) 
*Revision Note
and RT-PCR (usually 0.5-1 x 10
6
 cells for RNA extraction). In terms of cell purity, according to our 
findings, VECs cultured in AF-12 medium (without additional purification or endothelial medium 
replacement) showed at least 50%-60% typical endothelial cobblestone morphology within 3 
passages. We didn’t do endothelial phenotypic quantification on immunocytochemistry, but we 
presumed the actual number would be higher than morphological observation, as CD31 or DiI-Ac-
LDL positive cells were heterogeneous in morphology (not limited to cobblestone shape only).  
Point 4: “The authors suggest EBM culture can improve EC phenotype homogeneity at a sacrifice of 
proliferation, but does this approach create enough cells for an experimental assay?” 
Response: Yes. When used EBM for primary P0 VECs culture, there was cell apoptosis and 
endothelial colony disappear during the early stages, but the cells started to proliferate rapidly in later 
culture periods. For those VECs experiencing EBM switch at P1 or P2, they did not show 
dramatically decreased proliferation compared to AF-12 culture. To avoid confusion the P0 EBM 
finding has been removed from the manuscript. 
Point 5: “Do the authors recommend using EBM during whatever treatment would be performed, or 
switching to AF-12 Media?” 
Response: Once starting culture the VECs in EBM we would continue with EBM rather than 
switching to AF-12. For experiments specifically investigating VEC behaviour and function, we 
would recommend to use EBM rather than AF-12, as the former is more optimal in maintaining VEC 
phenotype.  
Point 6: “As a minor but important comment, having standard deviation bars on Figure 6 would be 
helpful to assess the expected variation in isolation quality and/or subsequent culture performance of 
the phenotypes of these cells.” 
Authors’ Response: We’ve added standard error bars on Figure 5 (original Figure 6) in the revised 
manuscript (n=3).  
 
Reviewer 2   
Point 1: “Not sure about numbering of subsections in M and M and in Results - what is editorial 
policy?” 
Response: We’ve removed the numbering of subsections in the revised manuscript. 
Point 2: “Line 88 - presumably valves showed no gross evidence of MMVD?” 
Response: We’ve addressed this point in the revised manuscript; please see Line 84-85. 
Point 3: “Line 102 - a bit more pre-amble on the media experiments would be useful, just to put them 
into context. Typo – passage (P1).” 
Response: We’ve addressed this point in the revised manuscript; please see Line 109-121. 
Point 4: “Line 110 - might be useful to add a third sub-heading on cell passage (see later comment).” 
Response: We have addressed this point in Line 104-107 in the revised manuscript. 
 Point 5: “Lines 117, 135 and 149 - cells from which passage were used on these experiments - was 
this consistent?” 
Response: We have addressed this point in Line 112, 200 and 222 in the revised manuscript.  
Point 6: “Lines 137 and 149 - details of slides - chamber slides mentioned.” 
Response: We have addressed this point in Line 147-148 in the revised manuscript. 
Point 7: “Line 164 - was detected by RT-PCR in VEC culture?” 
Response: We have addressed this point in Line 201-202 in the revised manuscript. 
Point 8: “Line 177 - was detected by RT-PCR for….?” 
Response: We have addressed this point in Line 223-224 in the revised manuscript. 
Point 9: “Move section on effect of culture medium (lines 182-196) to before section on VIC 
morphology and characterization to be consistent with Methods.” 
Response: We have moved this section as requested; see Line 214-220. 
Point 10: “Line 194 - typo - EBM.Both…” 
Response: We have addressed this point in the revised manuscript. 
Point 11: “Line 201 - Waxmann reference not in references.” 
Response: We have addressed this point Line 534 in the revised manuscript. 
Point 12: “Line 239 - ..although it did not preserve…?” 
Response:  We have addressed this point in the revised manuscript. 
Point 13: “Line 256 - Liu et al (2007),…” 
Response: We have addressed this point in the revised manuscript. 
Point 14: “Line 265 - Han 2013 - a or b?” 
Response: We cannot locate this comment in the original manuscript. Effectively has been resolved 
Point 15: “Several references in reference list are incorrect or incomplete - e.g. lines 381 and 386, 
Paranya reference has a space in it. There is variability in how journals are cited.” 
Response: We have addressed these inconsistencies and errors in the reference section of the revised 
manuscript. 
Point 16: “Images - quality of text on images is poor.” 
Response: We have improved the text quality in the revised manuscript. 
 
Point 17: “Figure 3 - top panel association of positive staining with cells shown in the bright field 
image is not as convincing as the other images.” 
Response: We have checked the image and can confirm that the bright field image is correctly 
matched with the fluorescence image. However, the focusing of the bright field image was not 
optimal. We have tried to enhance that by adjusting brightness and contrast of the bright field image 
in the revised manuscript. 
Point 18: “Figures 3 and 4 - for clarity legends should explain column titles - what do the target 
protein images show, what is the merged image.” 
Response: We have addressed this point in the revised manuscript. Please see legends of Figure 3 and 
6 (Figure 4 in original manuscript). 
 
 
 
 
Comments E Bloome 
 
1. The current Figure 4 is a copy of Figure 6, I think Figure 4 should be what was Figure 5 in the 
previous submission. 
 
Figure identities seem correct; will up-load fresh set of figure images. 
 
2. Cannot find Bischoff (2001) reference in the text. 
 
No Bischoff 2001 in the text or reference list. 
 
Comments A. Philby 
 
1. Please check author's initials, e.g. "D.A. Argyle". 
  
Changed to D.J. 
 
2. Some reformatting of the Corresponding author's details will be required. 
 
Not sure what is required. 
 
3. Most non-standard abbreviations should be defined when first used in the Abstract and again 
in the Main text. Abbreviations that do not need to be defined include PCR, ELISA, DNA and RNA. 
In the Abstract, please change "reverse transcription polymerase chain reaction (RT-PCR)" to 
"reverse transcription PCR". 
 
MS checked and corrected 
 
4. Groups of references cited in the text should be arranged chronologically according to the 
idiosyncratic journal style, e.g. "Aupperle et al., 2009; Aupperle et al., 2010; Black et al., 2005; 
Hadian et al., 2007; Han et al., 2010; Han et al., 2013b" should be cited as "Black et al., 2005; 
Hadian et al., 2007; Aupperle et al., 2009, 2010; Han et al., 2010, 2013b". 
 
Corrected; EndNote seems to think TVJ format is different! 
 
5. Most units should be separated from values by a space, although percentages should be 
written without a space. Similalry, when writing temperatures, the value should be separated 
from the symbol for degrees Celsius by a space, e.g. "37°C" should be written as "37 °C" using 
the Word symbol for degrees Celsius rather than a superscripted letter "o". 
 
MS checked and corrected 
 
6. Some reformatting of tables and figure legends will be required. 
 
Not sure what is required? 
 
7. Please check spacing and punctuation throughout the manuscript. 
 
Done. 
 
8. Please reformat the Highlights with bullet points and define abbreviations. Each Highlight 
should be no more than 125 characters including spaces. 
 
Done. 
*Revision Note2
Professor Brendan Corcoran 
Deputy Head of School 
 
  
  
 ROYAL (DICK) SCHOOL OF VETERINARY STUDIES 
 The University of Edinburgh 
 Easter Bush Campus 
 Roslin 
 Midlothian 
 EH25 9RG 
 0131 650 6241 
 http://www.vet.ed.ac.uk/ 
 
29/7/2014 
 
Please find attached “Canine Mitral Valve Interstitial and Endothelial Cell Culture and 
Characterisation” for consideration for publication in TVJ. 
 
The paper describes the culturing of valve interstitial and endothelial cells from canine 
mitral valves. This is important as there is increasing interest in using culture systems to 
investigate mechanisms of pathogenesis in canine mitral valve disease, not least because of 
the difficulties in sourcing native valves. 
 
No previous study has reported on canine VECs, which are much harder to grow than VICs, 
and previous reports of VICs have used techniques that only cultured migratory phenotypes. 
 
This study provides the basic information necessary for accurate VIC and VEC culture and 
the techniques required for accurate phenotyping. 
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